A61K 39/092
Streptococcus
Official title: {Streptococcus}
A61K39/092 (Streptococcus) appears on 834 US grants and 1,170 published applications in this corpus.
Search patents in A61K- Granted patents
- 834
- Published applications
- 1,170
- Assignees
- 446
- Inventors
- 1,658
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 5 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 8 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 12 | 0 |
| 1999 | 18 | 0 |
| 2000 | 8 | 0 |
| 2001 | 13 | 3 |
| 2002 | 8 | 13 |
| 2003 | 7 | 13 |
| 2004 | 13 | 22 |
| 2005 | 6 | 24 |
| 2006 | 14 | 25 |
| 2007 | 8 | 72 |
| 2008 | 23 | 47 |
| 2009 | 16 | 48 |
| 2010 | 13 | 40 |
| 2011 | 31 | 44 |
| 2012 | 26 | 43 |
| 2013 | 30 | 46 |
| 2014 | 42 | 65 |
| 2015 | 31 | 73 |
| 2016 | 44 | 47 |
| 2017 | 48 | 61 |
| 2018 | 43 | 48 |
| 2019 | 43 | 49 |
| 2020 | 45 | 68 |
| 2021 | 48 | 58 |
| 2022 | 34 | 59 |
| 2023 | 43 | 57 |
| 2024 | 39 | 69 |
| 2025 | 31 | 34 |
| 2026 | 21 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lipidated FLIPr and uses thereof in vaccine6 Oct 2026US 12,752,003 B2National Health Research Institutes
- Protective vaccine antigen against streptococcal infection15 Sep 2026US 12,734,228 B2The Regents of the University of California
- Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F15 Sep 2026US 12,734,229 B2Inventprise, LLC
- Immunogenic composition comprising multivalent Streptococcus pneumoniae polysaccharide-protein conjugates14 Jul 2026US 12,678,494 B2Celltrion Inc.
- Method for improving immunogenicity of protein/peptide antigen7 Jul 2026US 12,673,102 B2SinoCellTech Ltd.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Rhizavidin variants8 Oct 2026US 2026/0308208 A1Affinivax, Inc.
- Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof24 Sep 2026US 2026/0284170 A1Pfizer Inc.
- Method for manufacturing recombinant transferrin binding proteins and vaccine compositions comrpising same10 Sep 2026US 2026/0263594 A1
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
Most cited
By later US patents
- Immunogenic conjugates154US 4,673,574 A1987
- Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics104US 6,699,703 B1Genome Therapeutics Corporation · 2004
- Oligosaccharide conjugate vaccines99US 5,153,312 AAmerican Cyanamid Company · 1992
- Pneumococcal polysaccharide conjugate vaccine98US 5,623,057 AMerck & Co., Inc. · 1997
- Immunogenic conjugates93US 4,902,506 AUniversity of Rochester · 1990